Comparison between Par Drugs IPO and Parshva Enterprises IPO.
Par Drugs IPO is a SME Fixed Price IPO proposed to list at NSE SME while Parshva Enterprises IPO is a SME Fixed Price proposed to list at BSE SME.
| Par Drugs IPO | Parshva Enterprises IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt.Ltd. | Inventure Merchant Banker Services Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Pantomath Stock Brokers Pvt.Ltd. | Sernet Financial Services Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Par Drugs IPO is up to ₹8.10 Cr whereas the issue size of the Parshva Enterprises IPO is up to ₹3.46 Cr. The final issue price of Par Drugs IPO is ₹51.00 per share and of Parshva Enterprises IPO is ₹45.00 per share.
| Par Drugs IPO | Parshva Enterprises IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹51.00 per share | ₹45.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 2000 shares | 3000 shares |
| Fresh Issue Size | 15,88,000 shares | 7,68,000 shares |
| Fresh Issue Size (Amount) | up to ₹8.10 Cr | up to ₹3.46 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 15,88,000 shares | 7,68,000 shares |
| Issue Size Total (Amount) | up to ₹8.10 Cr | up to ₹3.46 Cr |
Par Drugs IPO opens on May 03, 2019, while Parshva Enterprises IPO opens on Jun 19, 2019. The closing date of Par Drugs IPO and Parshva Enterprises IPO is May 08, 2019, and Jun 21, 2019, respectively.
| Par Drugs IPO | Parshva Enterprises IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | May 03, 2019 | Jun 19, 2019 |
| Issue Close | May 08, 2019 | Jun 21, 2019 |
| Basis Of Allotment (Tentative) | May 13, 2019 | Jun 27, 2019 |
| Initiation of Refunds (Tentative) | May 14, 2019 | Jun 28, 2019 |
| Credit of Share (Tentative) | May 15, 2019 | Jun 28, 2019 |
| Listing date (Tentative) | May 16, 2019 | Jul 01, 2019 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Par Drugs IPO P/E ratio is , as compared to Parshva Enterprises IPO P/E ratio of .
| Par Drugs IPO | Parshva Enterprises IPO | |||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| ||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.55 | 100 | ||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 72.82 | 73.09 | ||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||
In the Par Drugs IPO Retail Individual Investors (RII) are offered 7,80,000 shares while in Parshva Enterprises IPO retail investors are offered 7,80,000 shares. Qualified Institutional Buyers (QIB) are offered in Par Drugs IPO and in Parshva Enterprises IPO.
| Par Drugs IPO | Parshva Enterprises IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 84,000 shares | 42,000 shares |
| QIB | ||
| NII | 7,78,000 shares | 3,84,000 shares |
| RII | 7,80,000 shares | 3,84,000 shares |
| Employee | 30,000 shares | |
| Others | ||
| Total | 15,88,000 shares | 7,68,000 shares |
Par Drugs IPO subscribed 5.74x in total, whereas Parshva Enterprises IPO subscribed 1.20x.
| Par Drugs IPO | Parshva Enterprises IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 3.48x | 1.65x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 7.97x | 0.74x |
| Employee (times) | 1.00x | |
| Other (times) | ||
| Total (times) | 5.74x | 1.20x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
